Peak cough flow and sputum substance P concentration in patients with neurodegenerative disease

Peak cough flow and sputum substance P concentration in patients with neurodegenerative disease - PCF and sputum SP in neurodegenerative disease patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020028

Enrollment

Registered

2015-12-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurodegenerative disease

Interventions

anti-PD drug, ACE-I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who fulfilled the diagnostic criteria of each neurodegenerative diseases

Exclusion criteria

Exclusion criteria: patients who showed cognitive impairment

Design outcomes

Primary

Measure	Time frame
Forced vital capacity, substance P	—

Countries

Japan

Contacts

Public ContactOsamu Kano

Toho University School of medicine Dept of Neurology

osamukano@aol.com0337624151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026